Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Liver DiseaseShort Bowel Syndrome
Interventions
DRUG

Lovaza (omega-3-acid ethyl ester)

supplied as 1gram transparent soft-gelatin capsules filled with yellow oil, dosage is 1gram per kilogram of body weight per day, not exceeding 4grams per day until normalization of liver function test

DIETARY_SUPPLEMENT

Corn oil

1 gram per kilogram body weight per day, not exceeding 4 grams

Trial Locations (1)

02115

Children's Hospital Boston, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Harvard University

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Boston Children's Hospital

OTHER

NCT01191177 - Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease | Biotech Hunter | Biotech Hunter